(Total Views: 850)
Posted On: 05/03/2022 12:54:59 AM
Post# of 153984
Re: thriftycents #122801
Quote:
Efficacy and safety of leronlimab in patients with nonalcoholic steatohepatitis: topline results of NASH01 clinical trial 25 June 2022 09:00 - 09:00
Just in case some don't read to the end of your post or go to your link, I cited the best part above.
WOW! Thanks for your post!
(13)
(0)
